We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.175 | 4.29% | 4.25 | 4.20 | 4.30 | 4.25 | 4.075 | 4.08 | 463,018 | 15:59:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.90 | 26.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/1/2017 08:44 | 26p should shortly become a support level. | weyweyumfozo | |
23/1/2017 08:41 | Approval from the most difficult nation on earth deserves a rerating at a far higher level. | weyweyumfozo | |
23/1/2017 08:27 | The French market is so prestigious to get, even a neolith would know how fussy the French are about treating their grapes. | squiresquire | |
23/1/2017 08:20 | Eastman commercialisation agreement for nematicide a month ago. Fungicide product approved for sale in France today. That is the two chief concerns about Eden dealt with. Happy days. | weyweyumfozo | |
23/1/2017 08:19 | LOL................. | birotop | |
23/1/2017 08:15 | Wow, worrying how people are suckered in! Bit of pampering from the times and another meaningless rns. Sad to see people buying in like this. | themattbarnes | |
23/1/2017 08:14 | Every wine producer is going to use this because to risk Botrytis is unthinkable if you have an option as clean as this one. Wonderful product can be used right up to harvest | squiresquire | |
23/1/2017 07:58 | "RNS Number : 7788U Eden Research plc 23 January 2017 Eden Research Plc ("Eden" or "Company") Fungicide product approved for sale in France Environmentally friendly product to combat botrytis (grape rot) in one of the world's largest wine producing nations Eden Research plc (AIM: EDEN), the AIM-listed company that provides breakthrough natural bio-control products and microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, announces that is has received authorisation in France for its first product, 3AEY, for use in the prevention and treatment of botrytis in table and wine grapes. 3AEY will be sold in France by Eden partner SumiAgro France under the brand name "Mevalone(TM)". This is a significant and long-awaited milestone for the Company and will allow SumiAgro France to sell Mevalone to its established customers. Mevalone is a terpene-based fungicide that can prevent and treat botrytis, a widespread fungal disease that causes grey mould on many fruits and vegetables leading to the rapid loss of commercially valuable crops. The average losses from affected crops account for around 20% of the total harvest, costing producers between EUR10-100 billion annually worldwide, depending upon weather conditions. The market for Botryticides alone is more than $350 million per annum."............. | weyweyumfozo | |
22/1/2017 20:30 | Check Tom W. on Shareprophets bearcast. | geoff80 | |
22/1/2017 16:04 | Good spot. I can't see it reported elsewhere on the net, which is quite odd. French approval has been a very long time coming, and seems important for this product. "A British bioscience company will help France produce more wine after winning approval to sell an environmentally friendly pesticide designed to prevent grape rot. Eden ..... has been granted permission to sell Mevalone, a product it has developed to combat botrytis, to vineyards in France. ..... a rare approval for a pesticide within the EU. The products are often rejected by watchdogs because of their potential for harming the environment. ...... Two years ago, France fell behind Italy as the world’s largest wine producing country.... In part, that was because of the prevalence of grape rot, which can be devastating to wine producers during hot and humid weather. The average losses from affected crops account for about 20% of the global harvest, costing producers as much as €100bn (£86.5bn) p.a. ..... The market for botryticides is estimated to be more than $350m (£283m).... | paulpaolo | |
22/1/2017 09:48 | Apparently article in Sunday Times today re Eden winning approval in France. If that is correct, RNS time on Monday and up she goes! Stand by yer beds....... | the prophet | |
02/1/2017 21:14 | super I have held here a long time and still fully intend to. Dont let your frothy get to you as he is a totally filthy person with a totally filthy mind, thought process and kharma. Let him roll he will ruin himself very well .. without help. | squiresquire | |
22/12/2016 16:32 | Mr Early certainly got a good list of legal phrases. 'Tortious interference' wow Sounding way more nasty than 'overlooked' ho ho ho | supersonico | |
22/12/2016 16:25 | On. The other hand Michael Walters appears bullish for the company's revised deal and prospects. | quazie12 | |
22/12/2016 16:24 | That aidanearley site is worth reading. | redhill9 | |
22/12/2016 12:21 | Q12, How many times can I repeat myself. If Frothy was serious and this was not just a vendetta he would get serious with Shore Cap.. Why do you think he uses the words 'overlooking' rather than 'wilful Blindness? | supersonico | |
22/12/2016 11:41 | But of course as Livingbridge have already done their DD here you ate already fine with it | quazie12 | |
22/12/2016 11:39 | SuperHave a proper look back at that TT transaction its all there at Companies House. | quazie12 | |
22/12/2016 07:10 | Q12 Strongly worded but not legal language like 'wilfully blind'. Keeping out of the swing as per usual. Not the actions of a confident man. Monotonous Vendetta Heavy analysis. Blue skies await supersonico. | supersonico | |
22/12/2016 05:42 | The 500k trade at 14p+ yesterday am must be hurting someone. 20% loss in a day ! Anyways I look forward to gem's rebuttal today of TW's strongly worded post on sharepuppets. I agree with pretty much all of it esp the TT valuation. One thing for sure the auditors are in a bit of a bind now with that. they valued the "asset" for that transaction with a very opaque basis of valuation in the Companies House lodging and I have been looking into the possibility of going after them for my loss on the basis that shareholders should be protected when a limited co uses shares to acquire "assets." I will keep you posted over the coming months on that front.RegardsQ12 | quazie12 | |
21/12/2016 17:50 | Q12, What do you make of these multiple £44k £72K £73K trades? | supersonico | |
21/12/2016 15:50 | Q12 I think you will find that the main reason folk get 'obsessed' about Frothy is his analysis is Vendetta weighted against M Walters and K Brooks and light on the real progress Eden are making. Eastman a massive NYSE company, Sipcam another Global player, LivingBridge and Shore Cap etal all disagree with Frothy on everything he says about both TT and the efficacy of the technology but he persists. How can anyone take him seriously when he describes Eden Tech as Fraudulent when it is validated by Global billion dollar companies... If he really was convinced of his case he would be describing Shore Cap as 'Wilfully blind'. He's not which speaks volumes. Blue skies still await Supersonico | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions